Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.
Foghsgaard S, Andreasen C, Vedtofte L, Andersen ES, Bahne E, Strandberg C, Buhl T, Holst JJ, Svare JA, Clausen TD, Mathiesen ER, Damm P, Gluud LL, Knop FK, Vilsbøll T. Foghsgaard S, et al. Among authors: bahne e. Diabetes Care. 2017 Jan;40(1):109-116. doi: 10.2337/dc16-1017. Epub 2016 Nov 3. Diabetes Care. 2017. PMID: 27810989
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.
Bahne E, Sun EWL, Young RL, Hansen M, Sonne DP, Hansen JS, Rohde U, Liou AP, Jackson ML, de Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due S, Wattchow DA, Rehfeld JF, Holst JJ, Keating DJ, Vilsbøll T, Knop FK. Bahne E, et al. JCI Insight. 2018 Dec 6;3(23):e93936. doi: 10.1172/jci.insight.93936. JCI Insight. 2018. PMID: 30518693 Free PMC article. Clinical Trial.
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.
Vedtofte L, Bahne E, Foghsgaard S, Bagger JI, Andreasen C, Strandberg C, Gørtz PM, Holst JJ, Grønbæk H, Svare JA, Clausen TD, Mathiesen ER, Damm P, Gluud LL, Knop FK, Vilsbøll T. Vedtofte L, et al. Among authors: bahne e. J Clin Med. 2020 Oct 6;9(10):3213. doi: 10.3390/jcm9103213. J Clin Med. 2020. PMID: 33036179 Free PMC article.
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Foghsgaard S, Vedtofte L, Andersen ES, Bahne E, Andreasen C, Sørensen AL, Forman JL, Mathiesen ER, Svare JA, Clausen TD, Damm P, Holst JJ, Knop FK, Vilsbøll T. Foghsgaard S, et al. Among authors: bahne e. Diabetes Obes Metab. 2024 Jan;26(1):201-214. doi: 10.1111/dom.15306. Epub 2023 Oct 17. Diabetes Obes Metab. 2024. PMID: 37846555 Clinical Trial.
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
Hansen LS, Gasbjerg LS, Brønden A, Dalsgaard NB, Bahne E, Stensen S, Hellmann PH, Rehfeld JF, Hartmann B, Wewer Albrechtsen NJ, Holst JJ, Vilsbøll T, Knop FK. Hansen LS, et al. Among authors: bahne e. Eur J Endocrinol. 2024 Aug 5;191(2):192-203. doi: 10.1093/ejendo/lvae095. Eur J Endocrinol. 2024. PMID: 39049802 Clinical Trial.
Distribution of particulate matter and tissue remodeling in the human lung.
Pinkerton KE, Green FH, Saiki C, Vallyathan V, Plopper CG, Gopal V, Hung D, Bahne EB, Lin SS, Ménache MG, Schenker MB. Pinkerton KE, et al. Among authors: bahne eb. Environ Health Perspect. 2000 Nov;108(11):1063-9. doi: 10.1289/ehp.001081063. Environ Health Perspect. 2000. PMID: 11102298 Free PMC article.